 Shawn McCandless
Concepts (384)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neonatal Screening | 12 | 2020 | 152 | 2.650 |
Why?
| | Urea Cycle Disorders, Inborn | 16 | 2020 | 22 | 2.280 |
Why?
| | Prader-Willi Syndrome | 7 | 2023 | 27 | 2.200 |
Why?
| | Phenylbutyrates | 12 | 2020 | 21 | 1.390 |
Why?
| | Metabolism, Inborn Errors | 6 | 2021 | 38 | 1.240 |
Why?
| | Glycerol | 11 | 2020 | 88 | 1.230 |
Why?
| | Abnormalities, Multiple | 6 | 2013 | 181 | 0.920 |
Why?
| | Phenylketonurias | 3 | 2023 | 13 | 0.860 |
Why?
| | Ammonia | 9 | 2020 | 65 | 0.840 |
Why?
| | Infant, Newborn | 28 | 2022 | 5255 | 0.770 |
Why?
| | Glutamine | 9 | 2018 | 88 | 0.750 |
Why?
| | Hyperphagia | 3 | 2023 | 32 | 0.710 |
Why?
| | Chromosome Deletion | 4 | 2010 | 95 | 0.700 |
Why?
| | Galactosemias | 1 | 2019 | 8 | 0.680 |
Why?
| | Cinnamates | 1 | 2017 | 9 | 0.620 |
Why?
| | Aminopeptidases | 1 | 2017 | 12 | 0.620 |
Why?
| | Cyclohexanes | 1 | 2017 | 22 | 0.620 |
Why?
| | Appetite Depressants | 1 | 2017 | 21 | 0.610 |
Why?
| | Epoxy Compounds | 1 | 2017 | 33 | 0.610 |
Why?
| | Sesquiterpenes | 1 | 2017 | 51 | 0.600 |
Why?
| | Acidosis | 1 | 2017 | 86 | 0.580 |
Why?
| | Protease Inhibitors | 1 | 2017 | 102 | 0.580 |
Why?
| | Genetic Testing | 4 | 2023 | 389 | 0.570 |
Why?
| | Lysosomal Storage Diseases | 1 | 2015 | 4 | 0.550 |
Why?
| | Glycoproteins | 1 | 2017 | 319 | 0.530 |
Why?
| | Public Health | 1 | 2020 | 450 | 0.530 |
Why?
| | Hyperammonemia | 4 | 2020 | 15 | 0.500 |
Why?
| | Parenteral Nutrition | 1 | 2015 | 92 | 0.490 |
Why?
| | Infant | 24 | 2023 | 8293 | 0.480 |
Why?
| | Consanguinity | 1 | 2013 | 49 | 0.460 |
Why?
| | Child, Preschool | 26 | 2022 | 9491 | 0.450 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2012 | 16 | 0.440 |
Why?
| | Hazardous Substances | 1 | 2012 | 12 | 0.440 |
Why?
| | Obesity | 2 | 2017 | 2746 | 0.410 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 770 | 0.410 |
Why?
| | Amino Acids | 1 | 2015 | 464 | 0.400 |
Why?
| | Humans | 70 | 2023 | 118972 | 0.380 |
Why?
| | Phenylalanine | 4 | 2023 | 66 | 0.370 |
Why?
| | Rare Diseases | 5 | 2019 | 113 | 0.350 |
Why?
| | Child | 29 | 2023 | 19129 | 0.340 |
Why?
| | Phenylacetates | 4 | 2020 | 10 | 0.320 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 992 | 0.320 |
Why?
| | Adolescent | 21 | 2023 | 18480 | 0.300 |
Why?
| | Feeding Behavior | 1 | 2012 | 601 | 0.290 |
Why?
| | Female | 41 | 2023 | 61564 | 0.290 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2013 | 2062 | 0.280 |
Why?
| | Male | 38 | 2021 | 57801 | 0.280 |
Why?
| | Young Adult | 14 | 2022 | 10793 | 0.270 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2005 | 51 | 0.260 |
Why?
| | Mutation | 8 | 2019 | 3457 | 0.260 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2005 | 33 | 0.260 |
Why?
| | Infant Formula | 2 | 2018 | 84 | 0.250 |
Why?
| | Methionine | 2 | 2021 | 145 | 0.250 |
Why?
| | Trisomy | 1 | 2005 | 66 | 0.250 |
Why?
| | False Positive Reactions | 2 | 2015 | 115 | 0.240 |
Why?
| | Neutropenia | 2 | 2022 | 133 | 0.240 |
Why?
| | Vitamin B 12 | 2 | 2021 | 115 | 0.240 |
Why?
| | Growth Disorders | 2 | 2019 | 77 | 0.240 |
Why?
| | Genetic Diseases, Inborn | 1 | 2003 | 46 | 0.230 |
Why?
| | Face | 2 | 2020 | 165 | 0.220 |
Why?
| | Glycogen Storage Disease Type I | 1 | 2022 | 4 | 0.220 |
Why?
| | Mass Spectrometry | 3 | 2004 | 681 | 0.220 |
Why?
| | Phenotype | 7 | 2019 | 3003 | 0.210 |
Why?
| | Leukodystrophy, Metachromatic | 1 | 2001 | 3 | 0.210 |
Why?
| | Cost of Illness | 1 | 2003 | 258 | 0.200 |
Why?
| | Strabismus | 1 | 2021 | 27 | 0.200 |
Why?
| | Metabolism | 1 | 2021 | 39 | 0.200 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2000 | 20 | 0.190 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 2 | 2021 | 19 | 0.190 |
Why?
| | Acyl-CoA Dehydrogenase | 3 | 2012 | 8 | 0.190 |
Why?
| | Prenatal Care | 1 | 2023 | 252 | 0.190 |
Why?
| | Double-Blind Method | 4 | 2023 | 1687 | 0.190 |
Why?
| | Hospitals, Pediatric | 1 | 2003 | 505 | 0.180 |
Why?
| | Alleles | 3 | 2019 | 832 | 0.180 |
Why?
| | Orphan Drug Production | 1 | 2019 | 6 | 0.180 |
Why?
| | Adult | 17 | 2022 | 31512 | 0.180 |
Why?
| | Mental Status and Dementia Tests | 1 | 2019 | 21 | 0.170 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 366 | 0.170 |
Why?
| | Registries | 4 | 2021 | 1810 | 0.170 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2019 | 75 | 0.170 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2018 | 23 | 0.170 |
Why?
| | DNA Polymerase II | 1 | 2018 | 29 | 0.170 |
Why?
| | Osteochondrodysplasias | 1 | 2018 | 15 | 0.170 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2019 | 60 | 0.170 |
Why?
| | Goldenhar Syndrome | 1 | 1998 | 4 | 0.170 |
Why?
| | Eye Abnormalities | 1 | 1998 | 10 | 0.170 |
Why?
| | Skin Abnormalities | 1 | 1998 | 10 | 0.170 |
Why?
| | Sensitivity and Specificity | 3 | 2017 | 1795 | 0.170 |
Why?
| | Fetus | 1 | 2023 | 690 | 0.170 |
Why?
| | Adrenal Insufficiency | 1 | 2018 | 30 | 0.160 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 2018 | 9 | 0.160 |
Why?
| | Endpoint Determination | 1 | 2018 | 69 | 0.160 |
Why?
| | Fructose Intolerance | 1 | 2018 | 6 | 0.160 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 1998 | 39 | 0.160 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1384 | 0.160 |
Why?
| | Prodrugs | 1 | 2018 | 44 | 0.160 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 48 | 0.160 |
Why?
| | Exome | 1 | 2019 | 220 | 0.160 |
Why?
| | Lipase | 1 | 2018 | 70 | 0.160 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2017 | 8 | 0.160 |
Why?
| | Methionyl Aminopeptidases | 1 | 2017 | 1 | 0.160 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2017 | 7 | 0.160 |
Why?
| | Ketones | 1 | 2017 | 45 | 0.160 |
Why?
| | Enzyme Assays | 1 | 2017 | 23 | 0.160 |
Why?
| | Early Termination of Clinical Trials | 1 | 2017 | 15 | 0.150 |
Why?
| | Intention to Treat Analysis | 1 | 2017 | 70 | 0.150 |
Why?
| | Parents | 3 | 2020 | 1212 | 0.150 |
Why?
| | Pediatricians | 1 | 2019 | 120 | 0.150 |
Why?
| | Body Mass Index | 2 | 2017 | 2092 | 0.150 |
Why?
| | Syndrome | 4 | 2020 | 344 | 0.150 |
Why?
| | Glutaryl-CoA Dehydrogenase | 1 | 2016 | 4 | 0.150 |
Why?
| | Brain Diseases, Metabolic | 1 | 2016 | 7 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 499 | 0.140 |
Why?
| | Patient Preference | 1 | 2018 | 170 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2018 | 136 | 0.140 |
Why?
| | United States | 6 | 2020 | 12555 | 0.140 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 1868 | 0.140 |
Why?
| | Prevalence | 2 | 2012 | 2326 | 0.140 |
Why?
| | Cognition | 2 | 2023 | 1024 | 0.140 |
Why?
| | Indians, North American | 1 | 2001 | 598 | 0.130 |
Why?
| | Venous Thrombosis | 1 | 2017 | 147 | 0.130 |
Why?
| | Mosaicism | 2 | 2005 | 62 | 0.130 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2015 | 68 | 0.130 |
Why?
| | Fibroblasts | 2 | 2017 | 842 | 0.120 |
Why?
| | Genetic Counseling | 1 | 2014 | 66 | 0.120 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2013 | 8 | 0.120 |
Why?
| | Hepatic Encephalopathy | 1 | 2013 | 22 | 0.120 |
Why?
| | Fetal Growth Retardation | 1 | 2018 | 468 | 0.120 |
Why?
| | Genotype | 1 | 2019 | 1882 | 0.110 |
Why?
| | Rape | 1 | 2013 | 35 | 0.110 |
Why?
| | Ubiquinone | 1 | 2012 | 25 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1945 | 0.110 |
Why?
| | Drug Substitution | 1 | 2013 | 46 | 0.110 |
Why?
| | Weight Loss | 1 | 2017 | 655 | 0.110 |
Why?
| | Siblings | 1 | 2013 | 235 | 0.110 |
Why?
| | Caregivers | 1 | 2018 | 709 | 0.110 |
Why?
| | Intellectual Disability | 3 | 2019 | 136 | 0.100 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 79 | 0.100 |
Why?
| | Carnitine | 2 | 2003 | 65 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2674 | 0.100 |
Why?
| | Self Report | 1 | 2015 | 699 | 0.100 |
Why?
| | Infant, Premature | 1 | 2015 | 480 | 0.100 |
Why?
| | Biomarkers | 3 | 2016 | 3588 | 0.100 |
Why?
| | Urinary Tract | 1 | 1991 | 40 | 0.100 |
Why?
| | Chromosomes, Human, Pair 19 | 1 | 2010 | 25 | 0.100 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 2 | 2021 | 16 | 0.100 |
Why?
| | Ectodermal Dysplasia | 1 | 2010 | 14 | 0.100 |
Why?
| | Surveys and Questionnaires | 4 | 2022 | 4708 | 0.100 |
Why?
| | Heart Defects, Congenital | 3 | 2010 | 703 | 0.100 |
Why?
| | Diaphragm | 1 | 2010 | 36 | 0.100 |
Why?
| | Homocysteine | 2 | 2021 | 137 | 0.100 |
Why?
| | Middle Aged | 10 | 2021 | 27617 | 0.090 |
Why?
| | Diseases in Twins | 1 | 1991 | 181 | 0.090 |
Why?
| | Vaginal Diseases | 1 | 2010 | 17 | 0.090 |
Why?
| | Algorithms | 1 | 2017 | 1541 | 0.090 |
Why?
| | Chromosome Banding | 2 | 2010 | 18 | 0.090 |
Why?
| | Mental Disorders | 1 | 1998 | 939 | 0.090 |
Why?
| | Risk | 1 | 2012 | 853 | 0.090 |
Why?
| | Liver | 3 | 2013 | 1816 | 0.090 |
Why?
| | Abdomen | 1 | 2010 | 110 | 0.090 |
Why?
| | alpha-Glucosidases | 1 | 2009 | 10 | 0.090 |
Why?
| | Glycogen Storage Disease Type II | 1 | 2009 | 7 | 0.090 |
Why?
| | Cysts | 1 | 2010 | 93 | 0.090 |
Why?
| | Cohort Studies | 2 | 2019 | 5116 | 0.080 |
Why?
| | Ultrasonography, Prenatal | 1 | 2010 | 227 | 0.080 |
Why?
| | Cytomegalovirus Infections | 1 | 2010 | 187 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2021 | 4596 | 0.080 |
Why?
| | Overweight | 1 | 2012 | 502 | 0.080 |
Why?
| | Gene Frequency | 2 | 2016 | 513 | 0.080 |
Why?
| | Cross-Over Studies | 3 | 2014 | 456 | 0.080 |
Why?
| | Iduronate Sulfatase | 1 | 2006 | 1 | 0.080 |
Why?
| | Mucopolysaccharidosis II | 1 | 2006 | 2 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2010 | 408 | 0.070 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 290 | 0.070 |
Why?
| | Sex Factors | 1 | 2012 | 1781 | 0.070 |
Why?
| | Time Factors | 2 | 2015 | 6412 | 0.070 |
Why?
| | Muscle, Skeletal | 2 | 2013 | 1515 | 0.070 |
Why?
| | Brain | 1 | 1998 | 2490 | 0.070 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2005 | 310 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2022 | 12978 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 171 | 0.070 |
Why?
| | Karyotyping | 1 | 2005 | 102 | 0.060 |
Why?
| | Chromosome Disorders | 1 | 2005 | 39 | 0.060 |
Why?
| | Diet | 1 | 2012 | 1153 | 0.060 |
Why?
| | Anxiety | 2 | 2023 | 845 | 0.060 |
Why?
| | Fragile X Syndrome | 1 | 2005 | 80 | 0.060 |
Why?
| | Quality of Life | 1 | 2015 | 2366 | 0.060 |
Why?
| | Pregnancy | 4 | 2023 | 5690 | 0.060 |
Why?
| | Microcephaly | 1 | 2005 | 54 | 0.060 |
Why?
| | Disease Management | 2 | 2019 | 571 | 0.060 |
Why?
| | Fatal Outcome | 2 | 2010 | 287 | 0.060 |
Why?
| | Lymphocytes | 3 | 2017 | 347 | 0.060 |
Why?
| | X Chromosome | 2 | 2000 | 47 | 0.060 |
Why?
| | Heterozygote | 2 | 2001 | 262 | 0.060 |
Why?
| | Gene Deletion | 1 | 2005 | 361 | 0.060 |
Why?
| | Neuropsychological Tests | 3 | 2019 | 1032 | 0.060 |
Why?
| | Radiography | 2 | 2010 | 861 | 0.060 |
Why?
| | Hyperhomocysteinemia | 1 | 2003 | 24 | 0.060 |
Why?
| | Food, Fortified | 1 | 2003 | 37 | 0.060 |
Why?
| | Carbon-Carbon Ligases | 1 | 2003 | 2 | 0.060 |
Why?
| | Cough | 2 | 2017 | 102 | 0.060 |
Why?
| | Oxytocin | 1 | 2023 | 44 | 0.060 |
Why?
| | Pedigree | 2 | 2001 | 485 | 0.060 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2017 | 245 | 0.060 |
Why?
| | Infant Food | 1 | 2003 | 63 | 0.060 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 70 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2005 | 371 | 0.050 |
Why?
| | Glucosides | 1 | 2022 | 39 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 148 | 0.050 |
Why?
| | Developmental Disabilities | 1 | 2005 | 247 | 0.050 |
Why?
| | Benzhydryl Compounds | 1 | 2022 | 60 | 0.050 |
Why?
| | Models, Genetic | 1 | 2005 | 595 | 0.050 |
Why?
| | Founder Effect | 1 | 2001 | 12 | 0.050 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2001 | 3 | 0.050 |
Why?
| | Homozygote | 2 | 2018 | 190 | 0.050 |
Why?
| | History, 19th Century | 1 | 2001 | 61 | 0.050 |
Why?
| | United States Indian Health Service | 1 | 2001 | 43 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 551 | 0.050 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 32 | 0.050 |
Why?
| | Hand Deformities, Congenital | 1 | 2000 | 8 | 0.050 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2000 | 21 | 0.050 |
Why?
| | Facies | 1 | 2000 | 22 | 0.050 |
Why?
| | Betaine | 1 | 2000 | 64 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2021 | 136 | 0.050 |
Why?
| | Warfare | 1 | 2001 | 77 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2021 | 230 | 0.050 |
Why?
| | Methyltransferases | 1 | 2000 | 61 | 0.050 |
Why?
| | History, 20th Century | 1 | 2001 | 281 | 0.050 |
Why?
| | Vitamins | 1 | 2021 | 158 | 0.050 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2019 | 6 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4552 | 0.040 |
Why?
| | Adrenoleukodystrophy | 1 | 1999 | 4 | 0.040 |
Why?
| | Public-Private Sector Partnerships | 1 | 2019 | 43 | 0.040 |
Why?
| | Angelman Syndrome | 1 | 1999 | 8 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2001 | 300 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 467 | 0.040 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2019 | 6 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2018 | 5 | 0.040 |
Why?
| | Genomic Imprinting | 1 | 1999 | 32 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2019 | 115 | 0.040 |
Why?
| | Incidence | 2 | 2021 | 2424 | 0.040 |
Why?
| | Cell Line | 1 | 2005 | 2707 | 0.040 |
Why?
| | Length of Stay | 1 | 2003 | 1032 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2000 | 292 | 0.040 |
Why?
| | Executive Function | 1 | 2023 | 391 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 300 | 0.040 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 1999 | 56 | 0.040 |
Why?
| | Urea | 1 | 2019 | 77 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 79 | 0.040 |
Why?
| | Cleft Lip | 1 | 1998 | 33 | 0.040 |
Why?
| | Drug Industry | 1 | 2019 | 104 | 0.040 |
Why?
| | Canada | 1 | 2019 | 340 | 0.040 |
Why?
| | North America | 1 | 2019 | 266 | 0.040 |
Why?
| | Europe | 1 | 2019 | 356 | 0.040 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2017 | 3 | 0.040 |
Why?
| | Cleft Palate | 1 | 1998 | 48 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2017 | 29 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 1997 | 280 | 0.040 |
Why?
| | Nitrogen | 1 | 2018 | 154 | 0.040 |
Why?
| | Skull | 1 | 1998 | 127 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 607 | 0.040 |
Why?
| | Biochemistry | 1 | 2017 | 40 | 0.040 |
Why?
| | DNA Replication | 1 | 2018 | 211 | 0.040 |
Why?
| | Global Health | 1 | 2019 | 310 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2020 | 378 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 1998 | 129 | 0.040 |
Why?
| | Recombinant Proteins | 3 | 2006 | 1308 | 0.040 |
Why?
| | Glutarates | 1 | 2016 | 6 | 0.040 |
Why?
| | Prospective Studies | 2 | 2019 | 6471 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 401 | 0.040 |
Why?
| | Cocaine | 1 | 1998 | 158 | 0.030 |
Why?
| | Child Behavior | 1 | 1998 | 212 | 0.030 |
Why?
| | Fever | 1 | 2017 | 283 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 953 | 0.030 |
Why?
| | Computational Biology | 1 | 2019 | 588 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1355 | 0.030 |
Why?
| | North Carolina | 2 | 2006 | 109 | 0.030 |
Why?
| | Cognition Disorders | 1 | 1999 | 529 | 0.030 |
Why?
| | Fasting | 1 | 2015 | 264 | 0.030 |
Why?
| | Primary Health Care | 1 | 2004 | 1560 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2016 | 421 | 0.030 |
Why?
| | Immunoglobulin G | 2 | 2009 | 788 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 9342 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 1998 | 448 | 0.030 |
Why?
| | Molecular Sequence Data | 3 | 2005 | 2871 | 0.030 |
Why?
| | Enzyme Stability | 2 | 2004 | 75 | 0.030 |
Why?
| | Pediatrics | 1 | 2020 | 985 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2012 | 26 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 1998 | 652 | 0.030 |
Why?
| | DNA Mutational Analysis | 2 | 2005 | 381 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 363 | 0.030 |
Why?
| | Blood Grouping and Crossmatching | 1 | 1991 | 16 | 0.030 |
Why?
| | Liver Transplantation | 1 | 2019 | 847 | 0.030 |
Why?
| | Transcription Factors | 1 | 2019 | 1570 | 0.030 |
Why?
| | DNA | 2 | 2010 | 1388 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2995 | 0.020 |
Why?
| | Physical Chromosome Mapping | 1 | 2010 | 16 | 0.020 |
Why?
| | Chromosome Breakage | 1 | 2010 | 20 | 0.020 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2010 | 20 | 0.020 |
Why?
| | Comparative Genomic Hybridization | 1 | 2010 | 28 | 0.020 |
Why?
| | Muscle Hypotonia | 1 | 2010 | 31 | 0.020 |
Why?
| | Colpotomy | 1 | 2010 | 2 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 736 | 0.020 |
Why?
| | Twins, Monozygotic | 1 | 1991 | 214 | 0.020 |
Why?
| | HLA Antigens | 1 | 1991 | 230 | 0.020 |
Why?
| | Interinstitutional Relations | 1 | 2010 | 55 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3443 | 0.020 |
Why?
| | Pilot Projects | 2 | 2006 | 1419 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4077 | 0.020 |
Why?
| | Tracheostomy | 1 | 2010 | 102 | 0.020 |
Why?
| | Glycogen | 1 | 2009 | 59 | 0.020 |
Why?
| | Escherichia coli | 2 | 2004 | 758 | 0.020 |
Why?
| | Aged | 2 | 2018 | 19657 | 0.020 |
Why?
| | Vagina | 1 | 2010 | 148 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2013 | 1244 | 0.020 |
Why?
| | Body Height | 1 | 2009 | 187 | 0.020 |
Why?
| | Skin Diseases | 1 | 2009 | 125 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6561 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2010 | 545 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 827 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2009 | 842 | 0.020 |
Why?
| | Glycosaminoglycans | 1 | 2006 | 78 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 612 | 0.020 |
Why?
| | Research Design | 1 | 2012 | 969 | 0.020 |
Why?
| | Joints | 1 | 2006 | 85 | 0.020 |
Why?
| | Echocardiography | 1 | 2009 | 556 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2006 | 57 | 0.020 |
Why?
| | Blood Specimen Collection | 1 | 2006 | 34 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 380 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2005 | 67 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2006 | 526 | 0.020 |
Why?
| | Myristic Acid | 1 | 2004 | 10 | 0.020 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2005 | 65 | 0.020 |
Why?
| | Safety | 1 | 2006 | 304 | 0.020 |
Why?
| | Spleen | 1 | 2006 | 510 | 0.020 |
Why?
| | Histidine | 1 | 2004 | 63 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2004 | 139 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 2004 | 70 | 0.020 |
Why?
| | Body Weight | 1 | 2009 | 934 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 1974 | 0.020 |
Why?
| | Tyrosine | 1 | 2004 | 233 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2004 | 276 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2004 | 522 | 0.010 |
Why?
| | Acids | 1 | 2003 | 20 | 0.010 |
Why?
| | Brain Edema | 1 | 2003 | 61 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2010 | 2513 | 0.010 |
Why?
| | Fatty Acids | 1 | 2006 | 407 | 0.010 |
Why?
| | Glutamic Acid | 1 | 2004 | 224 | 0.010 |
Why?
| | Lysine | 1 | 2004 | 248 | 0.010 |
Why?
| | Chaperonin 10 | 1 | 2001 | 3 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2003 | 131 | 0.010 |
Why?
| | Chaperonin 60 | 1 | 2001 | 14 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 940 | 0.010 |
Why?
| | Base Sequence | 1 | 2005 | 2159 | 0.010 |
Why?
| | Prion Proteins | 1 | 2000 | 4 | 0.010 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2000 | 26 | 0.010 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 1 | 2000 | 11 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 58 | 0.010 |
Why?
| | Prions | 1 | 2000 | 36 | 0.010 |
Why?
| | Exons | 1 | 2001 | 307 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2000 | 372 | 0.010 |
Why?
| | Protein Precursors | 1 | 2000 | 126 | 0.010 |
Why?
| | Amyloid | 1 | 2000 | 87 | 0.010 |
Why?
| | Protein Folding | 1 | 2001 | 250 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2000 | 510 | 0.010 |
Why?
| | Neoplasms | 1 | 2013 | 2179 | 0.010 |
Why?
| | Haplotypes | 1 | 2001 | 473 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1435 | 0.010 |
Why?
| | Wechsler Scales | 1 | 1999 | 57 | 0.010 |
Why?
| | Sequence Deletion | 1 | 1999 | 171 | 0.010 |
Why?
| | Temperature | 1 | 2001 | 622 | 0.010 |
Why?
| | Genetic Linkage | 1 | 1999 | 321 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 755 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2071 | 0.010 |
Why?
| | Social Behavior | 1 | 1999 | 276 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1999 | 1012 | 0.010 |
Why?
| | Rats | 1 | 2004 | 5392 | 0.010 |
Why?
| | Animals | 3 | 2004 | 33381 | 0.010 |
Why?
| | DNA Methylation | 1 | 1999 | 503 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2001 | 2874 | 0.010 |
Why?
| | Mice | 2 | 2000 | 15520 | 0.010 |
Why?
| | Genetic Variation | 1 | 1997 | 926 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2003 | 3174 | 0.010 |
Why?
| | Disease Progression | 1 | 1999 | 2490 | 0.010 |
Why?
|
|
McCandless's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|